end-stage renal disease

Increased Rates of Supplement-Associated Oxalate Nephropathy During COVID-19 Pandemic

mycolabadmin

During the COVID-19 pandemic, more people took dietary supplements and high-dose vitamin C for health reasons. However, this study found that excessive supplement intake led to a significant increase in a kidney disease called oxalate nephropathy, where calcium oxalate crystals damage the kidneys. The good news is that when patients stopped taking these harmful supplements, their kidney function often improved, emphasizing the importance of careful supplement use.

Kidney Injury Induced by High-Dose Chaga Mushroom Consumption: Experimental Evidence in a Rat Model

mycolabadmin

This study examined whether consuming large amounts of Chaga mushroom can damage the kidneys in rats. The researchers found that high-dose Chaga consumption led to kidney injury through accumulation of oxalate (a naturally occurring compound in the mushroom), causing oxidative damage and cell death in kidney tissue. The findings suggest that while Chaga mushroom is promoted as a health supplement, excessive long-term consumption may harm kidney function, particularly in susceptible individuals.

Ganoderma lucidum and Robinia pseudoacacia Flower Extract Complex Alleviates Kidney Inflammation and Fibrosis by Modulating Oxidative Stress

mycolabadmin

Researchers studied a natural supplement made from reishi mushroom and black locust flower to treat kidney disease. In laboratory and animal tests, this supplement reduced kidney damage by lowering harmful molecules called free radicals and controlling inflammation. The supplement worked by blocking specific pathways that cause kidney inflammation and scarring, suggesting it could be a helpful natural treatment for people with chronic kidney disease.

Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study

mycolabadmin

This study analyzed over 4,000 research papers published between 2014 and 2024 about how oxidative stress damages kidneys in diabetic patients. Researchers found that China and the United States lead this research field, with increasing focus on natural compounds and traditional medicines that can reduce harmful reactive oxygen species. The findings suggest future treatments for diabetic kidney disease should target oxidative stress through both conventional drugs and natural antioxidant compounds derived from plants and fungi.

Dual fungal endocarditis in a pediatric dialysis patient: First case of Aspergillus flavus and Candida parapsilosis co-infection

mycolabadmin

A 13-year-old boy with kidney disease requiring dialysis developed a rare dual fungal heart infection caused by two different fungi simultaneously. Doctors diagnosed the infection using heart imaging, blood tests, and tissue examination, then treated him with antifungal medications and two heart surgeries to remove infected tissue and replace a damaged heart valve. Despite the extreme rarity and severity of this condition, the patient survived, which had never been reported in children before.

Spectrum of Fungal Infections in Continuous Ambulatory Peritoneal Dialysis: A 20-Year Retrospective Study From a Tertiary Care Center

mycolabadmin

This study examined fungal infections in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) over 20 years at a major Indian hospital. Researchers identified various fungal species causing peritonitis, with Candida species being most common, but discovered increasingly rare fungi involved in these infections. The study found that proper identification of the specific fungus and testing for drug resistance is crucial for effective treatment, typically involving catheter removal and targeted antifungal medications.

Trichosporon species bloodstream infections in a tertiary care hospital in the western region of Saudi Arabia: A 7-year retrospective chart review from 2016 to 2022

mycolabadmin

This study examined a rare but dangerous fungal infection called Trichosporonosis that affects the bloodstream in hospitalized patients. Researchers found that this infection kills about 60% of patients despite treatment with antifungal medications. The infection is often caused by a fungus called Trichosporon asahii and typically occurs in patients with weakened immune systems who are already hospitalized and using catheters.

Low Antigen Titre Disseminated Cryptococcosis in Immunocompromised Hosts: Two Challenging Case Reports

mycolabadmin

Two patients with weakened immune systems developed serious fungal blood infections from Cryptococcus despite having unusually low levels of fungal markers in their blood. One was a kidney transplant patient and the other had HIV. Neither showed signs of brain infection, which is unusual for this disease. Both were successfully treated with aggressive antifungal medications once blood cultures confirmed the disseminated infection.

First human case of Eidernor doerrieniae colonization in a peritoneal dialysis catheter: A warning from silent contamination

mycolabadmin

A 52-year-old man on peritoneal dialysis noticed brownish particles in his dialysis catheter. Doctors identified the particles as a rare fungus called Eidernor doerrieniae, which had never been found in humans before. Although the patient had no symptoms, doctors immediately removed the catheter and treated him with antifungal medications, which successfully cured the infection. This case shows why patients and doctors should take visible particles in dialysis catheters seriously, even when there are no obvious signs of infection.

Fungal peritonitis in a patient on peritoneal dialysis caused by Hyphopichia burtonii: A rare pathogen in human infection

mycolabadmin

A woman with kidney disease on peritoneal dialysis developed an unusual fungal infection caused by Hyphopichia burtonii, a fungus typically found in spoiled food. The infection was diagnosed using advanced protein analysis technology and treated with antifungal medication after removing the dialysis catheter. Though extremely rare in humans, this case shows that unusual fungi can cause serious infections in patients with weakened immune systems and highlights the importance of considering these organisms when standard treatments don’t work.

Disease: end-stage renal disease